Morgan Stanley »

Atea Pharmaceuticals shares owned by Morgan Stanley

Quarter-by-quarter ownership of Atea Pharmaceuticals (AVIR) shares owned by Morgan Stanley from 13F filings

Historical chart of Morgan Stanley investment in Atea Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Atea Pharmaceuticals held by Morgan Stanley consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Atea Pharmaceuticals by Morgan Stanley

Quarter filed Position value Share count Share price at filing
2024-06-30 $1.2M 368k 3.31
2024-03-31 $1.6M 405k 4.04
2023-12-31 $1.2M 408k 3.05
2023-09-30 $795k 265k 3.00
2023-06-30 $1.6M 430k 3.74
2022-12-31 $2.1M 439k 4.81
2022-06-30 $2.6M 393k 6.71
2022-03-31 $3.1M 429k 7.22
2021-06-30 $17M 789k 21.45
2020-12-31 $4.5M 107k 41.78